Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.

MLA

Kim, Hee Man, et al. “Sorafenib Inhibits 5-Fluorouracil-Resistant Gastric Cancer Cell Growth.” Scandinavian Journal of Gastroenterology, vol. 52, no. 5, May 2017, pp. 577–84. EBSCOhost, https://doi.org/10.1080/00365521.2017.1278786.

APA

Kim, H. M., Kim, S. A., Park, S. B., Cho, J. H., & Song, S. Y. (2017). Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. Scandinavian Journal of Gastroenterology, 52(5), 577–584. https://doi.org/10.1080/00365521.2017.1278786

Chicago

Kim, Hee Man, Sun A Kim, Soo Been Park, Jae Hee Cho, and Si Young Song. 2017. “Sorafenib Inhibits 5-Fluorouracil-Resistant Gastric Cancer Cell Growth.” Scandinavian Journal of Gastroenterology 52 (5): 577–84. doi:10.1080/00365521.2017.1278786.